Medicinal/Biocidal Applications of Tin Compounds and Environmental Aspects: Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy

Tin Chemistry: Fundamentals, Frontiers, and Applications

Volumn , Issue , 2008, Pages 454-468

  Pettinari, Claudio ^a   Marchetti, Fabio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Dipeptides diorganotin(IV) complexes; Organotin compound cardiovascular activity; Organotin compounds anti fungal agents; Organotin compounds in lipids; Organotin compounds on human natural killer cells; Organotin(IV) compounds; Organotins insecticidal larvicidal activities; Quantitative structure activity relationship (QSAR) studies; Trialkyl and triphenyltin compounds and heme metabolism

Indexed keywords

EID: 84891283034     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470758090.ch4     Document Type: Chapter

References (87)

1. W. N. Aldridge and J. E. Cremer, Biochem. J., 61, 406 (1955) and references therein;
2. R. D. Kimbrough, Environmental Health Perspectives, 14, 51 (1976) and references therein.
3. G. J. M. Van der Kerk, and J. G. A. Luijten, J. Appl. Chem., 4, 314 (1954);
4. G. J. M. Van der Kerk and J. G. A. Luijten, J. Appl. Chem., 6, 56 (1956).
5. M. Gielen and E. R. Tiekink, 50Sn Tin Compounds and Their Therapeutic Potential in Metallotherapeutic Drugs and Metal-Base Diagnostic Agents: The Use of Metals in Medicine, M. Gielen and E. R. T. Tiekink (Eds), John Wiley & Sons, Ltd., Chichester, 2005, Ch. 22, pp. 421-439.
6. A. Penninks, M. Bol-Schoenmakers, and W. Seinen, Cellular Activity of Organotin Compounds in Relation to their Antitumor Series in Tin-Based Antitumor Drugs, M. Gielen (Ed.), NATO ASI Series, Springer, Berlin, 1990, p. 169;
7. C. Pettinari, F. Marchetti, A. Cingolani, A. Lonrenzotti, E. Mundorff, M. Rossi, and F. Caruso, Inorg. Chim. Acta, 262, 33 (1997).
8. A. J. Crowe, Antitumor ctivity of Tin Compounds in Metal Compounds in Cancer Therapy, S. P. Fricker (Ed.), Chapman & Hall, London, 1994, pp. 147-179;
9. A. K. Saxena and F. Huber, Coord. Chem. Rev., 95, 109 (1989).
10. M. Gielen, Coord. Chem. Rev., 151, 41 (1996).
11. A. H. Penninks and W. Seinen, Vet. Q., 6, 209 (1984).
12. M. Gielen, J. Braz. Chem. Soc., 14, 870 (2003), and the references cited therein;
13. N. Hoeti, J. Ma, S. Tabassum, Y. Wang, and M. Wu, J. Biochem., 134, 521 (2003);
14. N. M. Xanthopoulou, S. K. Hadjikakou, N. Hadjiliadis, M. Schurmann, K. Jurkschat, A. Michaelides, S. Skoulika, T. Bakas, J. Binolis, S. Karkabounas, and K. Charalabopoulos, J. Inorg. Biochem., 96, 425 (2003).
15. F. Chen, V. Vallyathan, V. Castranova, and X. Shi, Mol. Cell. BioChem., 222, 183 (2001).
16. A. Gennari, R. Bleumink, B. Vivani, C. L. Galli, M. Marinovich, R. Pieters, and E. Corsini, Toxicol. Appl. Pharmacol., 181, 27 (2002).
17. A. Gennari, R. Bleumink, B. Vivani, C. L. Galli, M. Marinovich, R. Pieters, and E. Corsini, Toxicol. Appl. Pharmacol., 169, 185 (2000).
18. J. Xiao, J. Cui, Y. Su, J. He, and J. Yao, J. Ch. Pharm. Sci., 2, 45 (1993).
19. D. De Vos, R. Willem, M. Gielen, K. E. Van Wingerden, and K. K. Nooter, Met. Based Drugs, 5, 179 (1998).
20. M. Gielen, P. Lelieveld, D. de Vos, H. Pan, R.Willem, M. Biesemans, and H. H. Fiebig, Inorg. Chim. Acta, 196, 115 (1992).
21. M. Gielen, Appl. Organometal. Chem. 16, 481 (2002) and references reported therein;
22. M. Gielen, M. Biesemans, D. de Vos, and R. Willem, J. Inorg. Biochem., 79, 139 (2000);
23. F. P. Pruchnik, M. Banbula, Z. Ciunik, M. Latocha, B. Skop, and T. Wilczok, Inorg. Chim. Acta, 356, 62 (2003);
24. M. Gielen, R. Willem, H. Dalil, D. de Vos, C. M. Kuiper, and G. J. Peters, Met. Based Drugs, 5, 83 (1998);
25. M. Gielen, H. Dalil, B. Mahieu, D. de Vos, M. Biesemans, and R. Willem, Met. Based Drugs, 5, 275 (1998);
26. M. Gielen, A. El Khloufi, M. Biesemans, A. Bouhdid, D. de Vos, B. Mahieu, and R.Willem, Met. Based Drugs, 1, 305 (1994);
27. M. Gielen, H. Ma, A. Bouhdid, H. Dalil, M. Biesemans, and R. Willem, Met. Based Drugs, 4, 193 (1997);
28. M. Kemmer,M. Gielen, M. Biesemans, D. de Vos, and R.Willem, Met. Based Drugs, 5, 189 (1998).
29. J. Koshy, V. G. Kumar Das, S. Balabaskaran, S. W. Ng, and N. Wahab, Met. Based Drugs, 7, 245 (2000);
30. M. Gielen, H. Dalil, M. Biesemans, B. Mahieu, D. De Vos, and R. Willem, Appl. Organometal. Chem. 13, 515 (1999);
31. M. Gielen, H. Dalil, B. Mahieu, M. Biesemans, and R. Willem, Appl. Organometal. Chem. 12, 855 (1998).
32. M. Kemmer, L. Ghys, M. Gielen, M. Biesemans, E. R. T. Tiekink, and R. Willem, J. Organomet. Chem. 582, 195 (1999);
33. M. Kemmer, M. Biesemans, M. Gielen, E. R. T. Tiekink, and R. Willem, J. Organomet. Chem. 634, 55 (2001).
34. F. Caruso, M. Bol-Schoenmakers, and A. H. Penninks, J. Med. Chem., 36, 1168 (1993).
35. Yin, Z.-J., Gao, and C.-H. Wang, Ch. J. Chem., 23, 928 (2005).
36. M. I. Khan, M. K. Baloch, and M. Ashfad, J. Organomet. Chem., 689, 3370 (2004).
37. M. I. Khan, M. Kaleem Baloch, and M. Ashfaq, Appl. Organometal. Chem., 19, 132 (2005).
38. M. I. Khan, M. K. Baloch, M. Ashfad, and Obaidullah, Appl. Organometal. Chem., 20, 463 (2006).
39. F. Barbieri, F. Sparatore, M. Cagnoli, C. Bruzzo, F. Novelli and A. Alama, Chem.-Biol. Interact., 134, 27 (2001);
40. F. Barbieri, M. Viale, F. Sparatore, A. Favre, M. Cagnoli, C. Bruzzo, F. Novelli and A. Alama, Anticancer. Res., 20, 977 (2000).
41. Q. Li, M. F. C. Guedes da Silva and A. J. L. Pombeiro, Chem. Eur. J., 10, 1456 (2004);
42. Q. Li, M. F. C. Guedes da Silva, Z. Jinghua and A. J. L. Pombeiro, J. Organomet. Chem., 689, 4584 (2004).
43. T. A. K. Al-Allaf, L. J. Rashan, A. Stelzner and D. R. Powell, Appl. Organometal. Chem., 17, 891 (2003).
44. M. Kemmer, H. Dalil, M. Biesemans, J. C. Martins, B. Mahieu, E. Horn, D. de Vos, E. R. T. Tiekink, R.Willem, and M. Gielen, J. Organomet. Chem., 608, 63 (2000).
45. M. Gielen, M. Biesemans, and R. Willem, Appl. Organometal. Chem., 19, 440 (2005).
46. T. Lebl, A. Smicka, J. Brus, and C. Bruhn, Eur. J. Inorg. Chem., 143 (2003).
47. F. P. Pruchnik, M. Barbula, Z. Ciunik, H. Chojnacki, B. Skop, M. Latocha, and T. Wilczok, J. Inorg. Biochem., 90, 149 (2002).
48. L. Tian, Y. Sun, H. Li, X. Zheng, Y. Cheng, X. Liu, and B. Qian, J. Inorg. Biochem., 99, 1646 (2005).
49. L. Tian, Y. Sun, B. Qian, G. yang, Y. Yu, Z. Shang, and X. Zheng, Appl. Organometal. Chem., 19, 1127 (2005).
50. A. Sanchez Gonzalez, J. S. Casas, J. Sordo, U. Russo, M. I. Lareo, and B. J. Regueiro, J. Inorg. Biochem., 39, 227 (1990);
51. J. S. Casas, A. Castineiras, E. Garcia Martinez, P. Rodriguez Rodriguez, U. Russo, A. Sanchez, A. Sanchez Gonzalez, and J. Sordo, Appl. Organometal. Chem., 13, 69 (1999);
52. P. Alvarez-Boo, J. S. Casas, M. D. Couce, E. Freijanes, A. Furlani, V. Scarcia, J. Sordo, U. Russo, and M. Varela, Appl. Organometal. Chem., 11, 963 (1997).
53. P. Alvarez Boo, J. S. Casas, E. E. Castellano, M. D. Couce, E. Freijanes, A. Furlani, U. Russo, V. Scarcia, J. Sordo, and M. Varela, Appl. Organometal. Chem., 15, 75 (2001).
54. P. Alvarez-Boo, J. S. Casas, A. Castineiras, M. D. Couce, E. Freijanes, A. Furlani, U. Russo, V. Scarcia, J. Sordo, and M. Varala, Inorg. Chim. Acta, 353, 8 (2003).
55. Y. Oshima, T. Akimoto,W. Tsukada, T. Yamasaki, K. Yamaguchi, and H. Kojima, Chem. Pharm. Bull., 17, 1492 (1969).
56. M. Nath, S. Pokharia, X. Q. Song, G. Eng, M. Gielen, M. Kemmer, M. Biesemans, R. Willem, and D. De Vos, Appl. Organometal. Chem., 17, 305 (2003).
57. A. Casini. L. Messori, P. Orioli, M. Gielen, M. Kemmer, and R. Willem, J. Inorg. Biochem., 85, 297 (2001).
58. M. Kemmer, M. Gielen, M. Biesemans, D. de Vos, and R. Willem, Met. Based Drugs, 5, 189 (1998).
59. C. Pettinari, F. Marchetti, and Q. Li, Main Group Met. Chem., 24, 53 (2001).
60. L. Dostal, A. Ruzicka, R. Jambor, V. Buchta, P. Kubanova, and J. Holecek, Met. Based Drugs, 9, 91 (2002).
61. V. I. Bregadze1, S. A. Glazun, P. V. Petrovskii, Z. A. Starikova, V. Ya. Rochev, H. Dalil, M. Biesemans, R. Willem, M. Gielen., and D. de Vos, Appl. Organometal. Chem., 17, 453 (2003);
62. M. Gielen, F. Kayser, O. B. Zhidkova, V. Ts. Kampel, V. I. Bregadze, D. de Vos, M. Biesemans, B. Mahieu, R. Willem, Metal-Based Drugs, 2, 37 (1995);
63. M. Gielen, A. Bouhdid, R.Willem, V. I. Bregadze, L. V. Ermanson, E. R. T. Tiekink, J. Organometal Chem., 501, 277 (1995);
64. E. R. T. Tiekink, M. Gielen, A. Bouhdid, R. Willem, V. I. Bregadze, L. V. Ermanson, S. A. Glazun, Met. Based Drugs, 4, 75 (1997).
65. G. Han and P. Yang, J. Inorg. Biochem., 91, 230 (2002).
66. G. Mirisola, A. Pellerito, T. Fiore, G. C. Stocco, L. Pellerito, A. Cestelli, and I. Di Liegro, Appl. Organomet. Chem., 11, 499 (1997);
67. A. Pellerito, T. Fiore, F. Maggio, A. M. Giuliani, L. Pellerito, and C. Mansueto, Appl. Organometal. Chem., 11, 707 (1997).
68. C. Syngai, B. Basu, S. Tushar, and A. Chatterjee, J. Environ. Pathol. Toxicol. Oncol., 20, 333 (2001).
69. W. D. Siegmann-Louda, E. C. Carraher Jr., M. Graham, R. Doucette, and L. Lanz, in: Proceedings of the 224th ACS National Meeting, Boston, MA, United States, August 18-22, 2002, PMSE-170 (Abstracts).
70. C. Pellerito, L. Nagy, L. Pellerito, and A. Szorcisk, J. Organomet. Chem., 691, 1733 (2006) and references therein.
71. S. Shahzadi, K. Shahid, S. Ali, M. Mazhar, and K. M. Khan, J. Iran. Chem. Soc., 2, 277 (2005).
72. S. W. Ng, J. M. Hook, and M. Gielen, Appl. Organometal. Chem. 14, 1 (2000);
73. S. W. Ng, W. Chen, and V. G. Kumar Das, J. Organomet. Chem., 412, 39 (1991).
74. M. Gielen, H. Dalil, D. de Vos, M. Biesemans,, and R. Willem, Met. Based Drugs, 5, 265 (1998).
75. T. Mancilla, L. Carrillo, L. S. Zamudio Rivera, C. Camacho Camacho, D. de Vos, H. Rahier, M. Gielen, M. Kemmer, M. Biesemans, and R. Willem, Appl. Organometal. Chem., 15, 593 (2001).
76. D. Kovala-Demertzi, V. N. Dokorou, J. P. Jasinski, A. Opolski, J. Wiecek, M. Zervou, and M. A. Demertzis, J. Organomet. Chem., 690, 1800 (2005).
77. M. Lòpez-Cardoso, P. Garcia y Garcia, R. Cea-Olivares, and M.- L. Villareal, Met. Based Drugs., 8, 333 (2002).
78. K. Pankiewicz, R. Kinas, W. J. Stec, A. B. Foster, M. Jarman, J. M. S. Van Maanen, J. Am. Chem. Soc., 101, 7712 (1979).
79. M. Gielen, A. Bouhdid, E. R. T. Tiekink, D. de Vos, R. Willem, Met. Based Drugs., 3, 75 (1996).
80. M. Gielen, K. Handlir, M. Hollein, and D. de Vos, Met. Based Drugs., 7, 233 (2000).
81. C. Ma, Q. Jiang,, and R. Zhang, Appl. Organometal. Chem., 17, 623 (2003).
82. B. K. Keppler, C. Silvestru, and I. Haiduc, Met. Based Drugs., 1, 73 (1993).
83. P. M. Samuel, D. de Vos, D. Raveendra, J. A. R. P. Sarmac, and S. Roy, Bioorg. Med. Chem. Lett., 12, 61 (2002).
84. C. Pettinari, F. Caruso, N. Zaffaroni, R. Villa, F. Marchetti, R. Pettinari, C. Phillips, J. Tanski, and M. Rossi, J. Inorg. Biochem., 100, 58 (2006).
85. B. K. Keppler, C. Friesen, H. Vongerichten, and E. Vogel, in Metal Complexes in Cancer Chemotherapy, B. K. Keppler (Ed.), VCH Publishers,Weinheim, Germany, 1993, pp. 297-323;
86. T. Schilling, B. K. Keppler, M. E. Heim, G. Niebch, H. Dietzfelbinger, J. Rastetter, and A. R. Hanauske, Invest. New Drugs, 13, 327 (1996);
87. D. Searle, P. J. Smith, N. A. Bell, L. A. March, I. W. Nowell, and J. D. Donaldson, Inorg. Chim. Acta, 162, 143 (1989).